177A
Kohjin Bio Co.,Ltd.
コージンバイオ
- Industry
- Chemicals
- Market
- Growth
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(thousand JPY)
Mar 2024
4,770,096
Mar 2025
5,206,287
Mar 2026
4,939,025
Operating profit(thousand JPY)
Mar 2024
596,822
Mar 2025
991,135
Mar 2026
341,536
Operating profit margin(%)
Mar 2024
12.51
Mar 2025
19.04
Mar 2026
6.92
Profit before tax(thousand JPY)
Mar 2024
635,601
Mar 2025
1,015,300
Mar 2026
332,261
Profit(thousand JPY)
Mar 2024
384,978
Mar 2025
794,759
Mar 2026
251,019
Total assets(thousand JPY)
Mar 2024
6,589,322
Mar 2025
9,066,648
Mar 2026
8,904,397
Cash and cash equivalents(thousand JPY)
Mar 2024
1,726,936
Mar 2025
2,949,267
Mar 2026
2,486,185
Cash flows from operating activities(thousand JPY)
Mar 2024
823,681
Mar 2025
915,551
Mar 2026
698,508
Cash flows from investing activities(thousand JPY)
Mar 2024
-577,354
Mar 2025
-1,090,901
Mar 2026
-867,672
Cash flows from financing activities(thousand JPY)
Mar 2024
-1,348
Mar 2025
1,376,032
Mar 2026
-320,756
Return on equity(%)
Mar 2024
12.1
Mar 2025
17.4
Mar 2026
4.3
Equity ratio(%)
Mar 2024
50.7
Mar 2025
63.8
Mar 2026
66.8
Earnings per share(JPY per share)
Mar 2024
92.43
Mar 2025
157.57
Mar 2026
49.11
Net assets per share(JPY per share)
Mar 2024
802.5
Mar 2025
1,131.12
Mar 2026
1,163.08
Dividend per share(JPY per share)
Mar 2024
14
Mar 2025
24
Mar 2026
10
Payout ratio(%)
Mar 2024
15.15
Mar 2025
15.23
Mar 2026
20.36
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.